+ All Categories
Home > Documents > US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst...

US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst...

Date post: 05-Aug-2020
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
23
INDUSTRY NOTE USA | Themes & Tactics US Insights January 31, 2018 US Insights Finding Fresh Arms in the Bottom of the 12th; Stocks That Can Still Work EQUITY RESEARCH AMERICAS Key Takeaway Amazingly, nine years into this expansion, economic growth seems to be strengthening. Still, with S&P operating margins close to all-time highs, 2017 having the best EPS growth rate since 2011, and 2018 growth expected to exceed 2017's, we believe there is appetite for analyst top picks which also have accelerating EPS growth from other than just tax, outsized op. margin expansion, were '17 laggards, or all three. Most Jefferies analysts published their 2018 outlooks in the last several weeks and while you may not be surprised to see some mega cap tech names among the top picks, there were also a number of less obvious, less well performing, turnaround-type stocks that ascended the ranks. Starting with the stocks that Jefferies analysts had recently listed as top picks for 2018, we looked for stocks with 2018 estimated earnings growth acceleration, 2018 expected margin expansion that's better than the respective sector, and 2017 underperformance vs. the sector. We weren't so rigid to require every name meet every one of the criteria--ultimately whether a name was included had much to do with analyst conviction levels and prospects for improvement. All of the selected stocks have one thing in common as far as Jefferies analysts are concerned--operationally, things can get better from here. Some have seen recent improvements, some have seen recent setbacks, but in all cases, there is a path to greater things driven by factors other than just tax. The improvement generally comes from one of several drivers, and we offer those below, along with the stocks that fit into each. Some stocks fit into more than one category, and in those cases we've listed them more than once. Also, though we tried to include all the stocks that made sense, since this was not as simple as just a screen, arguments could certainly be made for other stocks--it would be impossible to say that a piece like this is exhaustive. Underappreciated revenue opportunity. CELG, GLNG, GT, HAE, HOLX, KSS, MLM, PAGP, PX, SBGI, STLD, TXT, UAA, ULTA Accelerating cash flow/earnings growth. BIO, BLD, CASY, CJ, CVX, EXPE, FM CN, KMT, MCK, OMF, SBNY, SC, SYNH, TXN, UTX, WEX, WMB M&A. CASY, SC Cost savings. BLD, ERI, KMT Allocation of capital. GPS, OMF Please see analyst certifications, important disclosure information, and information regarding the status of non-US analysts on pages 19 to 23 of this report. Jefferies Equity Research * Equity Analyst (888) JEFFERIES [email protected] Laurence Alexander, CFA * Equity Analyst (212) 284-2553 [email protected] Brandon Couillard * Equity Analyst (212) 284-2462 [email protected] Raj Denhoy * Equity Analyst (212) 336-7070 [email protected] Ramsey El-Assal * Equity Analyst (212) 284-4649 [email protected] Jason Gammel § Equity Analyst +44 (0) 20 7029 8709 [email protected] Randy Giveans * Equity Analyst (713) 651-3829 [email protected] Casey Haire * Equity Analyst (212) 707-6418 [email protected] Brad Handler * Equity Analyst (212) 336-7249 [email protected] John Hecht * Equity Analyst 415-229-1569 [email protected] John Janedis, CFA * Equity Analyst (212) 284-2187 [email protected] Sheila Kahyaoglu * Equity Analyst (212) 336-7216 [email protected] David Katz * Equity Analyst (212) 323-3355 [email protected] Randal J. Konik * Equity Analyst (212) 708-2719 [email protected] Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 [email protected] Christopher LaFemina, CFA * Equity Analyst (212) 336-7304 [email protected] Mark Lipacis * Equity Analyst (415) 229-1438 [email protected] Christopher Mandeville, CFA * Equity Analyst (646) 805-5407 [email protected] Philip Ng, CFA * Equity Analyst (212) 336-7369 [email protected] Anthony Petrone, CFA * Equity Analyst (212) 708-2703 [email protected] Seth Rosenfeld, CFA § Equity Analyst +44 (0) 20 7029 8772 [email protected] Christopher Sighinolfi, CFA * Equity Analyst (212) 707-6420 [email protected] Brian Tanquilut * Equity Analyst (615) 963-8338 [email protected] Brent Thill * Equity Analyst (415) 229-1559 [email protected] Stephen Volkmann, CFA * Equity Analyst (212) 284-2031 [email protected] David Windley, CFA, CPA * Equity Analyst (615) 963-8313 [email protected] Stephanie Wissink * Equity Analyst (212) 284-1713 [email protected] Michael J. Yee * Equity Analyst (415) 229-1535 [email protected] * Jefferies LLC § Jefferies International Limited ^Prior trading day's closing price unless otherwise noted.
Transcript
Page 1: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

INDUSTRY NOTE

USA | Themes & Tactics

US Insights January 31, 2018

US InsightsFinding Fresh Arms in the Bottom of the12th; Stocks That Can Still Work

EQU

ITY R

ESEARC

H A

MERIC

AS

415-229-1569 [email protected] Janedis, CFA *

Equity Analyst(212) 284-2187 [email protected]

Sheila Kahyaoglu *Equity Analyst

(212) 336-7216 [email protected] Katz *Equity Analyst

(212) 323-3355 [email protected] J. Konik *

Equity Analyst(212) 708-2719 [email protected]

Ashik Kurian §Equity Analyst

+44 (0)20 7029 8785 [email protected] LaFemina, CFA *

Equity Analyst(212) 336-7304 [email protected]

Mark Lipacis *Equity Analyst

(415) 229-1438 [email protected] Mandeville, CFA *

Equity Analyst(646) 805-5407 [email protected]

Philip Ng, CFA *Equity Analyst

(212) 336-7369 [email protected] Petrone, CFA *

Equity Analyst(212) 708-2703 [email protected]

Seth Rosenfeld, CFA §Equity Analyst

+44 (0) 20 7029 8772 [email protected] Sighinolfi, CFA *

Equity Analyst(212) 707-6420 [email protected]

Brian Tanquilut *Equity Analyst

(615) 963-8338 [email protected] Thill *Equity Analyst

(415) 229-1559 [email protected] Volkmann, CFA *

Equity Analyst(212) 284-2031 [email protected]

David Windley, CFA, CPA *Equity Analyst

(615) 963-8313 [email protected] Wissink *

Equity Analyst(212) 284-1713 [email protected]

Michael J. Yee *Equity Analyst

(415) 229-1535 [email protected]

* Jefferies LLC § Jefferies International Limited

^Prior trading day's closing price unlessotherwise noted.

Key TakeawayAmazingly, nine years into this expansion, economic growth seems to bestrengthening. Still, with S&P operating margins close to all-time highs, 2017having the best EPS growth rate since 2011, and 2018 growth expected toexceed 2017's, we believe there is appetite for analyst top picks which alsohave accelerating EPS growth from other than just tax, outsized op. marginexpansion, were '17 laggards, or all three.

Most Jefferies analysts published their 2018 outlooks in the last several weeksand while you may not be surprised to see some mega cap tech names amongthe top picks, there were also a number of less obvious, less well performing,turnaround-type stocks that ascended the ranks. Starting with the stocks thatJefferies analysts had recently listed as top picks for 2018, we looked for stocks with 2018estimated earnings growth acceleration, 2018 expected margin expansion that's better thanthe respective sector, and 2017 underperformance vs. the sector. We weren't so rigid torequire every name meet every one of the criteria--ultimately whether a name was includedhad much to do with analyst conviction levels and prospects for improvement.

All of the selected stocks have one thing in common as far as Jefferies analystsare concerned--operationally, things can get better from here. Some have seenrecent improvements, some have seen recent setbacks, but in all cases, there is a path togreater things driven by factors other than just tax. The improvement generally comes fromone of several drivers, and we offer those below, along with the stocks that fit into each.Some stocks fit into more than one category, and in those cases we've listed them morethan once. Also, though we tried to include all the stocks that made sense, since this wasnot as simple as just a screen, arguments could certainly be made for other stocks--it wouldbe impossible to say that a piece like this is exhaustive.

Underappreciated revenue opportunity. CELG, GLNG, GT, HAE, HOLX, KSS, MLM,PAGP, PX, SBGI, STLD, TXT, UAA, ULTA

Accelerating cash flow/earnings growth. BIO, BLD, CASY, CJ, CVX, EXPE, FM CN, KMT,MCK, OMF, SBNY, SC, SYNH, TXN, UTX, WEX, WMB

M&A. CASY, SC

Cost savings. BLD, ERI, KMT

Allocation of capital. GPS, OMF

Please see analyst certifications, important disclosure information, and information regarding the status of non-US analysts on pages 19 to 23 of this report.

Jefferies Equity Research *Equity Analyst

(888) JEFFERIES [email protected]

Laurence Alexander, CFA *Equity Analyst

(212) 284-2553 [email protected]

Brandon Couillard *Equity Analyst

(212) 284-2462 [email protected]

Raj Denhoy *Equity Analyst

(212) 336-7070 [email protected]

Ramsey El-Assal *Equity Analyst

(212) 284-4649 [email protected]

Jason Gammel §Equity Analyst

+44 (0) 20 7029 8709 [email protected]

Randy Giveans *Equity Analyst

(713) 651-3829 [email protected]

Casey Haire *Equity Analyst

(212) 707-6418 [email protected]

Brad Handler *Equity Analyst

(212) 336-7249 [email protected]

John Hecht *Equity Analyst

415-229-1569 [email protected]

John Janedis, CFA *Equity Analyst

(212) 284-2187 [email protected]

Sheila Kahyaoglu *Equity Analyst

(212) 336-7216 [email protected]

David Katz *Equity Analyst

(212) 323-3355 [email protected]

Randal J. Konik *Equity Analyst

(212) 708-2719 [email protected]

Ashik Kurian §Equity Analyst

+44 (0)20 7029 8785 [email protected]

Christopher LaFemina, CFA *Equity Analyst

(212) 336-7304 [email protected]

Mark Lipacis *Equity Analyst

(415) 229-1438 [email protected]

Christopher Mandeville, CFA *Equity Analyst

(646) 805-5407 [email protected]

Philip Ng, CFA *Equity Analyst

(212) 336-7369 [email protected]

Anthony Petrone, CFA *Equity Analyst

(212) 708-2703 [email protected]

Seth Rosenfeld, CFA §Equity Analyst

+44 (0) 20 7029 8772 [email protected]

Christopher Sighinolfi, CFA *Equity Analyst

(212) 707-6420 [email protected]

Brian Tanquilut *Equity Analyst

(615) 963-8338 [email protected]

Brent Thill *Equity Analyst

(415) 229-1559 [email protected]

Stephen Volkmann, CFA *Equity Analyst

(212) 284-2031 [email protected]

David Windley, CFA, CPA *Equity Analyst

(615) 963-8313 [email protected]

Stephanie Wissink *Equity Analyst

(212) 284-1713 [email protected]

Michael J. Yee *Equity Analyst

(415) 229-1535 [email protected]

* Jefferies LLC § Jefferies International Limited

^Prior trading day's closing price unless otherwise noted.

Page 2: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

Stocks Included and Respective Drivers

Underappreciated Revenue Opportunity

Celgene (CELG) – Mike Yee believes the market fails to appreciate the value of the

pipeline and sees upcoming pipeline catalysts including mid-‘18 luspatercept data in

MDS and potentially best-in-class JUNO JCAR17 pivotal data

Golar LNG (GLNG) - LNG spot charter rates and FLNG production expected to boost the

top line.

Goodyear Tire (GT) - After spotty results, company recently preannounced on better

volumes, but ’18 could be even better on reversal of share losses and net price/raw

material tailwind.

Haemonetics (HAE) - New product NexSys highly value creative for customers and

should result in better terms for the company.

Hologic (HOLX) - Estimates for Cynosure likely finally low enough as the salesforce has

finally stabilized.

Kohl’s (KSS) – Traction in proprietary brands, progress in active wear, traffic from new

initiatives (accepting Amazon returns and selling Amazon smart home products in certain

stores) and share gains from peer store closures should help drive the top line.

Martin Marietta (MLM) - Aggregates shipments should finally inflect in '18 on a return

of public spend and efforts from state DoTs to alleviate labor constraints and get projects

done.

Plains GP Holdings (PAGP) - Company has the best Permian assets in midstream and

should see strong Permian volume growth in '18.

Franchise Pick - Praxair (PX) - Compelling late cycle stock benefitting from a better

capex cycle, better merchant gas pricing and deal synergies.

Sinclair Broadcasting (SBGI) – The SBGI/TRCO combination should improve retrans

growth at TRCO. 2018 midterm elections a positive for broadcasters.

Steel Dynamics (STLD) - Benefits from strength in steel prices, potential infrastructure

demand and potentially from Section 232.

Franchise Pick - Textron (TXT) - New aviation products should drive demand even in a

flattish market and various signs point to improvement in the bizjet market.

ULTA Cosmetics (ULTA) - Sales growth is settling into a sustained range, company has

hinted at international expansion and the opening of additional metropolitan stores.

Company showed strong growth in Tribe’s most recent earned media value data.

Franchise Pick - Under Armour (UAA) - Stock doesn't reflect the international

opportunity, category remains strong, recent management changes generally positive.

Accelerating Cash Flow/Earnings Growth

Bio-Rad (BIO) - EPS growth expected to accelerate again as the company harvests

efficiencies from the new ERP.

Franchise Pick - Casey’s General Stores (CASY) - Activist involvement could lead to a

sale at a large premium and/or the company engaging in continued cost control and

M&A on its own.

Themes & Tactics

US Insights

January 31, 2018

page 2 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 3: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

C&J Energy Services (CJ) – Company expected to generate cash after losses in 2017.

Margin and pricing dynamics in CJ’s non-fracking IS onshore completions strong.

Franchise Pick - Chevron (CVX) - Capex investments over the past several years now

bearing fruit, boosting production and cash flow.

Expedia Inc. (EXPE) - Cloud investments should slow and once completed, should

drive margin accretion through elimination of duplicate systems. Fundamentals are

strong despite recent weak result.

First Quantum (FM CN) - Cash flow improves as Cobre comes online, capex rolls off

and copper hedges reset.

Kennametal (KMT) – Steve believes the macro backdrop for machinery is as good as

it’s been in years but also sees a self-help story with KMT having 1000bps of margin

upside over the next several years as operations are streamlined.

McKesson (MCK) - Generic price declines no longer getting worse, stock at a 5+ point

discount to the S&P 500.

OneMain (OMF) – Credit has stabilized following an integration related uptick in NCOs

in 2016-2017, company likely to consider a capital returns program in 2019.

Franchise Pick- Santander Consumer (SC) - Company is coming off two years of

declining earnings but credit stability should help drive earnings growth in '18. Potential

for the parent bank to take out the remaining 30% stake.

Signature Bank (SBNY) – Exposure to taxi medallions played a part in 2017

underperformance but that issue is now largely behind the bank. Casey expects SBNY to

announce a buyback and/or implement a dividend by year end ’18.

Syneos (SYNH) - Stock too severely punished on the rocky start to the inVentiv deal,

clinical business remains strong and Dave Windley sees a significant inflection in F19

(Mar) numbers on deal synergies.

Franchise Pick - Texas Instruments (TXN) – Mark looks for 20%+ EPS growth in 2018,

due partly to IoT growth and the budding US capex cycle. Mark also looks for 1000bps of

margin expansion as semiconductor consolidation leads to pricing power.

Top Build (BLD) – Still room for expansion in new residential construction and margins

are well below closest comp IBP, something that’s being addressed with capital lease

accounting and product offering.

United Technologies (UTX) – Sheila Kahyaoglu expects margins to bottom in '18 on

Pratt’s GTF issues, Otis pricing trends have begun to improve.

Franchise Pick - WEX Inc. (WEX) – 2018 numbers should benefit from the recovery of

2017 skimming/fraud losses, new contract wins, higher fuel prices and is one of the

bigger tax beneficiaries.

Williams Companies (WMB) – Company should see improved ’18 results on

expansion project contributions and dissipated commodity derived headwinds.

M&A

Franchise Pick - Casey’s General Stores (CASY) - Activist involvement could lead to a

sale at a large premium and/or the company engaging in continued cost control and

M&A on its own.

Themes & Tactics

US Insights

January 31, 2018

page 3 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 4: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

Franchise Pick - Santander Consumer (SC) - Company is coming off two years of

declining earnings but credit stability should help drive earnings growth in '18. Potential

for the parent bank to take out the remaining 30% stake.

Cost Savings

Top Build (BLD) – Still room for expansion in new residential construction and margins

are well below closest comp IBP, something that’s being addressed with capital lease

accounting and product offering.

Eldorado Resorts (ERI) – Company is focusing on better managing promotional

expenditures, also has the ability to monetize underutilized land.

Kennametal (KMT) – Steve believes the macro backdrop for machinery is as good as

it’s been in years but also sees a self-help story with KMT having 1000bps of margin

upside over the next several years as operations are streamlined.

Allocation of Capital

Franchise Pick - Gap Inc. (GPS) - Expected to allocate toward the brands faring best,

which should help drive Old Navy to 80% of company profits.

OneMain (OMF) – Credit has stabilized following an integration related uptick in NCOs

in 2016-2017, company likely to consider a capital returns program in 2019.

Themes & Tactics

US Insights

January 31, 2018

page 4 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 5: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

Operating Margins Already Close to All-Time Highs, Though Street Expecting New Highs in ‘18

Chart 1: S&P 500 Operating Margin

Source: Bloomberg, Jefferies

‘17 Growth the Best Since ‘11, ‘18 Expected to Be Better, But this Follows Years of Sub-Par Growth

Chart 2: S&P 500 Historical Operating Margins and EPS Growth

Source: Bloomberg, Jefferies Dotted line and hashed column indicate consensus estimates

5.0%

7.0%

9.0%

11.0%

13.0%

15.0%

17.0%

0%

2%

4%

6%

8%

10%

12%

14%

16%

18%

-40%

-30%

-20%

-10%

0%

10%

20%

30%

40%

50%

EPS Growth Operating Margin

Themes & Tactics

US Insights

January 31, 2018

page 5 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 6: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

Still, The New Highs in Margins Has Much to Do With Strong Upward Trend in Tech Margins

Chart 3: S&P 500 Cyclical Sector Operating Margins

Source: Bloomberg, Jefferies Dotted lines are for consensus estimates

Forward P/E Highest Since Tech Bubble, but Has Compressed Recently as NTM EPS Have Risen

Chart 4: S&P 500 Forward P/E

Source: Bloomberg, Jefferies

-15%

-10%

-5%

0%

5%

10%

15%

20%

25%

30%

Consumer Disc. Energy Financials

Industrials Tech Materials

5

7

9

11

13

15

17

19

21

23

25

Themes & Tactics

US Insights

January 31, 2018

page 6 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 7: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

2017 S&P Return Was Well in Excess of Average

Chart 5: S&P 500 Annual Total Return

Source: Bloomberg, Jefferies

Numerous Groups Have Underperformed the S&P since ’15, Namely Energy

Chart 6: Relative Total Return by S&P 500 Industry Group (’15 – Current)

Source: Bloomberg, Jefferies

-40%

-30%

-20%

-10%

0%

10%

20%

30%

40%

19

90

19

91

19

92

19

93

19

94

19

95

19

96

19

97

19

98

19

99

20

00

20

01

20

02

20

03

20

04

20

05

20

06

20

07

20

08

20

09

20

10

20

11

20

12

20

13

20

14

20

15

20

16

20

17

Annual Total Return Average

-60% -40% -20% 0% 20% 40% 60%

S&P 500RETAILINGSEMI & SEMI EQPSFTW & SVCSCONS SRVBANKSHC EQUIP & SVCTECH HW & EQPCAPITAL GDSDIV FINANCIALINSURANCEFD BEV & TOBMATERIALSTRANSPTNComm & Prof ServMEDIATELECOMM SVCSPHRM BIO & LF SCUTILITIESFOOD/STPL RETAILAUTO & COMPCON DUR & APREAL ESTATEHH & PR PDTSENERGY

Themes & Tactics

US Insights

January 31, 2018

page 7 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 8: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

Analyst Commentary on Selected Stocks

Consumer

John Janedis – Media & Entertainment

Sinclair Broadcast Group (SBGI, Buy, PT $48) – John recently initiated coverage

with a Buy rating on the premise that the market materially underappreciated the benefits

from the TRCO transaction. He notes that following the TRCO transaction, SBGI will reach

72% of the country, making the company the largest affiliate group for FOX, ABC and the

CW. As a result, SBGI’s leverage with MVPDs and networks should improve, which John

thinks could drive retrans growth of 20%+ in TRCO's stations in '18E. He expects this,

combined with cost savings, could contribute more than $600M in EBITDA to SBGI. His

standalone SBGI estimates are ahead of consensus and he also points out that the stock

trades with a ~20% FCF yield.

Randy Konik – Dept. Stores & Specialty Softlines

Franchise Pick - Gap (GPS, Buy, PT: $45) – Randy expects the top-line momentum to

continue, supported by additional marketing investments, while margins should continue

to expand as capital is allocated towards the higher margin divisions. He believes this

should drive accelerated earnings growth as management expands the Old Navy and

Athleta store bases, continues to gain market share and grows the online business (which

is margin accretive), while closing underperforming Gap and Banana Republic stores. His

proprietary data scrapes illustrate ASP increases at Gap and Old Navy in each of the last

four months, as well as decreases in discounting at Old Navy the last three months. Based

on this, he expects the Gap brand should see continued gradual improvement. 3Q

pointed to the turn progressing, with improvements in traffic and conversion, plus

traction in key categories (denim, Gap Body). Old Navy has significantly less mall

exposure and a smaller footprint relative to fast fashion peers, and will eventually increase

from 70% to 80% of company profits. As a result Randy believes GPS’s top-line and

margins should expand ahead of expectations in FY’18 and beyond, which should result

in upward EPS revisions and multiple expansion.

Kohl’s (KSS, Buy, PT: $100) – Randy believes Kohl’s is well-positioned in the current

retail environment and shares are poised to rise significantly higher as multiple catalysts

strengthen fundamentals and cause shares to rerate higher. Traction in proprietary

brands, progress in active wear, share gains from peer store closures, thoughtful traffic-

driving initiatives (e.g., Amazon) and a more productive new store prototype are a few

aspects of the KSS story that we think are underappreciated by investors. Despite

strengthened fundamentals and many catalysts ahead, valuation remains depressed vs.

peak levels, comparable peers and the market. He forecasts FY’19 EPS of $6.25, FY’20 EPS

of $7.50, and has a PT of $100.

Themes & Tactics

US Insights

January 31, 2018

page 8 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 9: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

Franchise Pick - Under Armour (UAA, Buy, PT: $24) – In 2017, Randy

underestimated the difficulties of management transition, bloated cost structure, slowing

sales and rising competition from Adidas. However, he remains bullish on UAA for 2018

believing the brand is not broken, management direction is improving and numbers are

finally bottoming. He believes the current market cap does not reflect the large global

TAM and growth ahead for UAA. Executive turnover is stabilizing, product misses are

improving and the company is lapping the TSA bankruptcy. Randy thinks their issues can

be fixed with better product, inventory control and more direct distribution. He likes

UAA's positioning in a strong category that has limited competition (UA, Adidas, Nike),

and points out that the brand is not over-distributed, with only ~half as many doors in NA

vs. NKE. He continues to believe UAA is one of three brands that matters in athletic, which

is a good LT category, and continues to see asymmetric risk/reward.

David Katz – Gaming

Eldorado Resorts (ERI, Buy, PT: $41) – The company has created value thus far by

acquiring under-managed companies and improving profitability. At the moment, it is

progressing on integrating ISLE, which it acquired in ‘17, where David believes there is

considerable value to capture. At a time when the industry is focusing on managing

promotional expenditures more effectively, ERI is a leader, which he thinks offers a 250-

500bps opportunity over the next two to three years. The near-term catalysts involve the

monetization strategies for three large parcels of land, in Pompano, Columbus and West

Virginia, which David believes should increase the value of the company. David thinks the

current valuation does not reflect both the ownership of real estate, as well as operations.

Ashik Kurian – Autos/Auto Parts

Goodyear (GT, Buy, PT: $42) – Ashik recently raised his ‘18 estimates ~5% following

pre-announced better Q4 results. The beat, amidst a challenging backdrop and modest

guidance, was driven primarily by volume growth. His new 2018 SOI estimate of $1.8B is

at the low end of GT's guidance, which seems conservative as it does not factor in reversal

of share losses in ’17, nor any net price/raw material tailwind. Numbers should also

benefit from the weak dollar and Ashik sees limited inventory risk for the industry too as

we start the year. GT’s implied >6% FCF yield, off of his $550M FCF forecast, should

support further re-rating of shares.

Chris Mandeville – Grocery and Convenience Retail

Franchise Pick - Casey’s General Stores (CASY, Buy, PT: $143) – Although CASY

underperformed the broader market in 2017 (-16%), Chris views the company favorably

over the next 12-24 months. As a result of management’s newfound cost control religion,

food costs locked in at favorable pricing through C2018 and assuming modestly better

comps (vs. easing compares), Chris expects EBITDA/EPS growth to rebound strongly in

2H18 with further improvement in F2019 (9%/7% ex-tax reform vs. 3%/-9%).

Additionally, while Chris already appreciated CASY’s growth story as a premier food-

focused c-store operator and consolidator of the industry, this is now a win/win situation

for investors as an activist has gotten involved and is pushing for a sale, which Chris thinks

could bring a significant premium to the current share price (+25-50% upside based on

historical transactions and our view of the quality of CASY’s assets) if investors grow

impatient. On the flipside of being acquired, CASY can also continue to pursue M&A of its

own. Chris likes the idea of CASY buying a portion of KR’s c-stores (165 of 784 found

within CASY’s distribution centers’ radii), which could provide low-to-mid teens accretion.

CASY is also the largest benefactor from tax reform across his coverage.

Themes & Tactics

US Insights

January 31, 2018

page 9 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 10: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

Brent Thill – Internet

Expedia (EXPE, Buy, PT: $170) – Expedia is a market share leader (by gross bookings)

that continues returning capital to shareholders through regular dividends and

opportunistic stock repurchases. So far in 2018, EXPE is trading in line with the market

and Brent expects continued double-digit revenue growth and margin improvement to

drive outperformance, most likely in 2H18. While competition remains tough, he doesn’t

think a tougher recent (late October) print reflects a change in EXPE fundamentals, or a

behavioral consumer shift to direct bookings or a meaningful impact from alternative

accommodations. Over the last couple of years, EXPE has built a solid portfolio of travel

assets, and now that they are integrated on a common base, platform efficiencies are

starting to show up in operating results. Brent also expects incremental efficiencies from

the migration of EXPE’s global brands to the Cloud. Over the near term, this move is

putting pressure on margins (over $150M in Cloud expenses in 2018) but once transition

is over, eliminating duplicate systems would drive further margin accretion. Brent models

150bps Operating Margin improvement in 2018 (more upside in the 2H) and ~20% EPS

growth, with further improvement in 2019. On top of that, EXPE remains one of the

cheapest stocks in our coverage universe – trading at over 30% discount to large cap

Internet names on forward EV/EBITDA and over 70% discount on forward EV/Sales.

Stephanie Wissink – Cosmetics, Household & Personal Care

Ulta Beauty (ULTA, Buy, PT: $300) – Steph remains positive on ULTA and forecasts

20%+ earnings growth over the near-medium term. She believes sales rates are settling

into a sustained range and forecasts meaningful margin expansion in the near-term.

Steph also notes that the acceleration in cash flow adds capital allocation optionality and

company management has hinted at international expansion and the opening of

additional metropolitan stores. Assuming ULTA continues to take share in beauty, with

improved cost leverage and share buybacks, Steph sees $14+ of potential annual EPS.

ULTA shares currently trade at 23x FY19 earnings and Steph’s $300 PT implies shares

trade at 30x.

Energy

Jason Gammel – Integrated Oil

Franchise Pick - Chevron (CVX, Buy, PT: $152) – Jason believes the Chevron

portfolio is the most strategically advantaged in the super-major sector, with visible

growth and an industry-leading Permian position. Chevron now begins to harvest the

yield from a major expansion in capital expenditures that began in 2011 and Jason

expects an organic production CAGR of 5.6% through 2020, including 10% in 2018.

Capital expenditures are falling, and he believes the company has considerable potential

for free cash generation and assumes that the company will increase the dividend by 5%

annually. Jason also estimates the company would have sufficient free cash flow to fund a

$32B share repurchase through 2020.

Themes & Tactics

US Insights

January 31, 2018

page 10 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 11: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

Randy Giveans – Maritime Group

Golar (GLNG, Buy, PT: $40) – Randy sees plenty of upside despite the recent run for

three reasons: 1) LNG spot charter rates are at four-year highs of $80,000 per day (the last

time they were at this level, the stock was trading near $40 per share); 2) LNG production

from Golar’s first FLNG project, the Hilli, is expected in the coming weeks as the vessel is

already hooked-up to the subsea anchor system in Cameroon; and 3) Golar is expected to

make a positive final investment decision on its second FLNG project, the Fortuna, in the

first quarter of 2018. The last hurdle to FID is finalizing the terms of the financing

package, which is likely contingent upon first production from the Hilli.

Brad Handler – Oilfield Services & Equipment

C&J Energy Services (CJ, Buy, PT: $40) - Brad likes CJ’s diversified set of NAM

completions-related offerings, because he sees some of the best pricing and margin

dynamics in US onshore in CJ’s non-fracking completions segments (~30% of 2018E

revenue) and believes there is multiple expansion potential for the company as investors

come to appreciate that. At the same time, Brad feels generally comfortable that CJ’s

fracking business (50% of 2018E revenues) is better than some may fear and supportive of

pumping industry fundamentals through 2019. As a result, he projects FCF will inflect in

’18 as CJ generates $150M, following losses in ‘17. Finally, Brad is encouraged by

management's efforts to divest/rationalize non-core/less-profitable businesses and sees

attractive earnings and asset-based valuation.

Chris Sighinolfi – MLPs

Plains GP Holdings (PAGP, Buy, PT: $26) – Despite warehousing the most enviable

Permian assets in the broader midstream group, PAGP is currently trading at a ~2.0x

discount to the 2019 peer average (EV/EBITDA). Two dividend reductions, large capital

raises (common and preferred) and guidance missteps over the last two years caused the

shares to weaken vs. the group, underperforming the AMZ Index by ~23% in 2017.

However, Chris believes volume growth, particularly in the Permian, as well as a

strengthening balance sheet and execution of its financial targets will prompt investors to

return to Plains All American in ‘18. Chris expects Permian transportation volumes to

grow 11% YoY in 2018 to 3,159 MBbld. Moreover, there exists a wide chasm between the

value of private Permian asset transactions and the value currently embedded in Plains

shares, indicating other avenues of potential investor support.

Williams Companies (WMB, Buy, PT: $37) – Trading at a ~1.2x discount to the peer

average EV/2019 EBITDA and a ~2.7x discount to the premium-priced peers, Chris

believes WMB offers an opportunity for improved 2018 returns given expansion project

contributions and dissipated commodity-derived headwinds. He sees ROE expanding to

~11% by 2019 from just ~5% in 2017 and the dividend rising to $1.35 in 2018 (~4.1%

implied yield). In the last 18 months, WMB has streamlined its asset profile (selling its

Canadian and petrochemical assets), reconstituted its Board (10 of 11 directors are now

independent), reduced leverage by nearly 1.0x of EBITDA, simplified its corporate

structure with the eradication of its MLP’s IDRs and solidly executed on organic

expansions. Chris expects WMB DCF to grow ~6% YoY in ’18, following continued

strength from Transco, Atlantic Sunrise in-service and declines in ethane rejection

providing an immediate-term tailwind for its Keep-whole and POP-oriented processing

business. The stock trades at a material discount to the group and he notes that every

1.0x of 2019E EBITDA is $6/share or 18% of current price.

Themes & Tactics

US Insights

January 31, 2018

page 11 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 12: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

Financials

Casey Haire – Regional Banks

Signature Bank (SBNY, Buy, PT: $178) – Casey expects SBNY to rebound in 2018

after underperforming meaningfully in ‘17. SBNY’s exposure to taxi medallions, which

suffered outsized losses, played a big part in SBNY’s underperformance last year.

However, he feels the overhang is removed given the magnitude of write-downs and the

fact that it makes up only 1% of total loans. Further, recent steepening of the yield curve

bodes well for the NIM outlook, which Casey believes can stabilize after getting squeezed

last year. Lastly, SBNY is a big tax reform winner (tax rate goes to 27% from 40%), which

will dramatically improve profitability and open the door for capital return opportunities,

given that equity is poised to outrun asset growth. Casey expects SBNY to announce a

share buyback and/or implement a dividend by year-end ’18, while still maintaining an

above average growth profile relative to peers. Valuation is attractive at 12.9x 2018 EPS,

which is a 10% discount vs. peers; the historical relative average has been a 13%

premium.

John Hecht – Consumer Finance

OneMain (OMF, Buy, PT: $48) – OMF is a top pick of John’s for 2018 following the

removal of technical pressures, improving fundamentals and the ongoing discount versus

peers. John notes that credit has stabilized following an integration-related uptick in

NCOs in 2016-2017. As a result, he expects the growing focus on secured lending should

diminish loss variability as well. He believes the competitive environment remains

balanced and that OMF will continue to be able to grow its book through the online/store

combination while the company is preparing for more online originations going forward.

Given the evident optimization of the capital structure, the decrease of the D/TCE ratio to

9.5x from 11.5x, high capital returns and current reserve levels, John thinks management

will consider a capital returns program in '19. The company has diversified its funding

sources, reducing reliance on capital markets and enabling growth even in periods of

capital market dislocation. Given improving credit trends, strong loan growth

opportunities and balance sheet bolstering, John remains favorable on OMF, especially as

shares trade at a substantial discount to peers at just 7x his ’18 EPS estimate.

Franchise Pick - Santander Consumer (SC, Buy, PT: $23) – John believes SC has

reached an inflection point for credit which should buttress both EPS growth and returns

on capital going forward. He expects the improving credit quality and the plateauing of

TDR migration will support growing EPS into FY18 and FY19, which should be an

ongoing positive catalyst for the stock. In addition, he also likes the increased flexibility

provided by recent positive regulatory developments, including capital returns on the

back of strong TBV growth and a relatively strong ROE. Tangible book value has

appreciated over 55% since 12/2014, a pace of nearly 16% per year on average. John

forecasts TBV growing to nearly ~$18.20 by FYE18. He believes 2017 marks the tail end of

trough returns as credit stabilizes, and forecasts the ROE improving in 2018. Finally, he

highlights the potential for the parent bank to take out the remaining 30% public stake.

Themes & Tactics

US Insights

January 31, 2018

page 12 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 13: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

Healthcare

Brandon Couillard – Life Sciences & Diagnostic Tools

Bio-Rad (BIO, Buy, PT: $300) – Post the recent completion of its new global ERP

system, 2018 marks a key inflection year for BIO as it begins to harvest efficiencies,

eliminate redundant costs and optimize its supply chain. Brandon sees ‘18 as the start of a

multi-year period of accelerating revenue growth, outsized margin expansion and

industry-leading EPS growth. He forecasts 270bps of EBITDA margin (>3x peers) and

nearly 50% EPS growth in ‘18 (4-5x peers). Tax reform & accelerated capital deployment

are both likely sources of earnings upside going forward, as well. BIO remains Brandon’s

top idea and he sees room for more upside as it executes on its self-help opportunities in

'18.

Raj Denhoy – Medical Supplies & Devices

Hologic (HOLX, Buy, PT: $52) – Raj’s Buy thesis is predicated on the totality of

HOLX’s portfolio (Breast Health, Diagnostics, Surgical, Aesthetics) being well positioned

to drive sustained top-line growth at the upper end of peers (5-7%). The HOLX story has

started to move beyond the self-inflicted wounds from trading the blood-screening

business for Cynosure. Roughly half of CYNO’s salesforce has turned over since the

acquisition was announced in February. Since then, all senior sales positions have been

filled with legacy HOLX executives, and most sales positions have been filled. Quarterly

revenues seem to have bottomed and forecasts look low enough. The reality is that

Cynosure is less than 12% of HOLX revenue and the other 88% of the business is doing

very well. This, paired against an industry high op margin profile, 32%+ and upside from

US tax reform sets HOLX up to be a low-teens EPS growth story for the next several years.

Anthony Petrone – Medical Supplies & Devices

Haemonics (HAE, Buy, PT: $75) – Anthony’s Buy thesis is predicated on HAE

maintaining 75-80% share of the global plasma collection market with its next gen

platform, the NexSys System. His bottoms-up model on NexSys points to $18 per donor

in potential economic value creation for collectors/processors (HAE’s end customers) on a

combination of faster throughput, higher plasma yields and reduced error. Should this

prove accurate in ongoing trials, HAE will be positioned for favorable terms later this year.

Assuming HAE can capture 20-30% of the $18 EVA from NexSys would drive a $4-$6 ASP

benefit per kit. Looking ahead to F2021, the first full roll-out year, this would drive $144-

$234M in revenue upside and EPS to $6.50+, nearly double that of current consensus.

When applying the 5-yr historical PE of 21x, Anthony sees visibility to share upside in the

$125-150 range.

Brian Tanquilut– Healthcare Services

MCK (Tanquilut, Buy, PT: $205) Brian recently upgraded the stock to Buy on the

back of his analysis of generic pricing, which highlighted an emerging stabilization trend.

Brian expects this trend to persist throughout '18, which he believes will drive improved

earnings and LT margins for MCK, resulting in multiple expansion. He thinks MCK's

exposure to AMZN risk is fairly limited given that med supplies account for only ~5% of

EBITDA. In addition, Brian believes Street EPS estimates are too low as few analysts have

adjusted for the ~$200M in estimated tax reform benefits. Shares currently trade at a 5.5

turn discount to the S&P vs. the 10Y historical average discount of 1.5 turns. His $205 PT

implies 20% upside from current levels.

Themes & Tactics

US Insights

January 31, 2018

page 13 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 14: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

Dave Windley – Pharmaceutical Svcs.

Syneos (SYNH, Buy, PT: $55) – Investors have reacted negatively to a rocky early start

to the INC Research/inVentiv Health merger. Importantly, that rocky start really only

applies to 30% of revenue and 25% of EBITDA. Further, Dave has been hearing investors

express concern that the business may "go away." In his experience, that has been an

overreaction for some time. Conversely, order trends for the clinical business (75% of

EBITDA) have been industry leading. Dave views that as a very positive sign of customers’

attitudes toward the merger. His EPS estimates for ‘18 are above consensus, but he thinks

the ’19 ramp is more important as synergies drive outsized EPS growth.

Mike Yee – Biotechnology

Celgene (CELG, Buy, PT: $125) – Mike continues to expect a rebound for shares in

’18 as the market gains better appreciation for the pipeline. He believes this could be

largely driven by upcoming catalysts that include: 1) mid-‘18 luspatercept data in MDS,

which could be a $1B+ drug and reinforce management’s business development strategy;

2) upcoming, potentially best-in-class JUNO JCAR17 pivotal data, which would show the

ability to drive leadership in cell therapy; 3) bb2121 pivotal data potentially by YE; and 4)

a potential settlement with Dr. Reddy's on IP. In addition, Mike would expect the

company to return to executing through earnings, particularly with Otezla and Revlimid,

and expand margins to highlight the power of inherent operational leverage. Lastly, he

expects the company to continue to engage in opportunistic M&A.

Industrials

Sheila Kahyaoglu – Aerospace & Defense Electronics

United Technologies (UTX, Buy, PT: $157) – Sheila highlights that It appears Pratt is

making headway on the GTF with its improved engine receiving greater acceptance from

airlines. We estimate negative engine mix headwind was ~$650M in 2016, increasing to

$850M in ‘17 and expect $1.15B in ‘18. This translates into ~$350MM mix headwind for

2018 earnings across Pratt's large engine platforms. Operating margins should bottom in

2018 and steadily improve in 2019 and 2020, particularly as volume grows across

Commercial, PWC and Military franchises. In addition, price has impacted Otis for the past

several years, but trends have begun to improve. Within CC&S, price has been favorable

thus far; however, the Middle East and China continue to be areas to watch. In total,

Sheila forecasts segment earnings growth of 3% in 2018, accelerating to 10% in 2019.

Her survey work has shown support in the aftermarket for the deal with COL, which she

expects to be accretive in ’19.

Franchise Pick - Textron (TXT, Buy, PT: $68) – Sheila highlights that TXT has the

potential for significant organic growth given its new product pipeline. New products in

Aviation should drive demand in a flattish market, while margin dynamics should

improve. Sheila estimates that R&D investment and mix resulted in $105M or $0.25 of

earnings headwind in 2017. Improved market dynamics and some investment holiday

should lead to higher earnings growth in 2018/19. Looking further out, contributions

from Bell’s V-280 program, which are not expected until 2023, could drive an additional

$1.50 in EPS, but non this this appears to be priced in at all. She thinks this growth

outlook is not reflected in the current 10-20% valuation discount to peers.

Themes & Tactics

US Insights

January 31, 2018

page 14 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 15: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

Phil Ng – Building Products

TopBuild (BLD, Buy, PT: $89) BLD has had strong stock performance over the past

year, but Phil continues to believe it can sustain strong top-line and earnings growth

through end market improvements, pricing, M&A and margin improvement. New

residential construction (~80% of sales) still sits ~20% below normalized levels and is

expected to continue to grow given the resurgence of the first time homebuyer,

household formations, healthy consumer balance sheets and relatively low interest rates.

This should drive high single digit top-line growth (both volume and price) and operating

margin improvement. BLD’s margins also lag IBP, its best public comp, but Phil expects

the gap to close as: 1) BLD switches from operating lease accounting to capital lease

accounting, which should yield ~120 bps of margin improvement over the next two to

three years; 2) they optimize the product offering, reducing services and products to

correct its margin profile; and 3) business leverage improves as the larger footprint is

better suited to operate at higher levels of new residential construction activity.

Additionally, the company should see a robust improvement in after-tax earnings and

cash flow given the new tax bill with its strictly domestic earnings profile, which should

enhance its FCF and allow the company to continue to consolidate a fragmented

installation and distribution industry at multiples roughly half of where it currently trades.

Martin Marietta (MLM, Buy, PT: $265) MLM saw weak stock price performance in

2017 with declining public spending on highways and streets weighing on aggregates

shipments. However, Phil believes aggregates shipments will inflect in 2018 and sees a

multi-year recovery with federal (FAST Act) and state level funding finally starting to come

through, and State DoTs alleviating labor constraints to get projects out the door.

Improvements in volumes should drive solid margin expansion with incremental gross

margins historically being in the 60% range. The company should also benefit from a

lower U.S. federal tax rate given its U.S. centric earnings providing management with

additional capital to deploy in M&A and internal investment. Phil also likes the recent Blue

Grass acquisition, which should close soon and provide upside to Street estimates.

Steve Volkmann – Machinery

KMT (Volkmann, Buy, PT: $60) – Steve thinks the current macro environment

indicates the best fundamental setup he has seen in years for the machinery group. That

being said, with valuations across the space stretched, and with potential for longer term

momentum to fade, Steve would remain selective and finds self-help story KMT attractive.

At present KMT stands out for three reasons, in his view: 1) it is highly levered to short

cycle manufacturing operating expenditures and should be early to see any signs of

recovery; 2) the company appears to have 1,000+ bps of margin upside as operations are

streamlined over the next two to three years; and 3) valuation is relatively attractive,

trading at 10x Steve’s ’19 EV/EBITDA, below the upper end of the historical range of 13x.

While Steve’s ’18 EPS estimate $2.55 in in line with the current consensus, he sees room

for upside driven by margin expansion and any uptick in short cycle expenditures.

Themes & Tactics

US Insights

January 31, 2018

page 15 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 16: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

Information Technology

Ramsey El-Assal – Payments, Processors & IT Services

Franchise Pick - WEX (WEX, Buy, PT: $202) – Ramsey continues to view WEX as an

attractive asset with high margins, a healthy top-and bottom-line growth profile, and a

defensive moat in the core fleet card segment. He further believes WEX is well-positioned

in 2018 due to: 1) high (mid-to-high-teens) EPS impact from tax reform; 2) the recovery of

2017 skimming/fraud losses; 3) new contract wins (Verizon, GSA, Chevron); 4)

anniversarying the Expedia contract renewal; and 5) a meaningful tailwind from higher

YoY fuel prices. The stock currently trades at ~19.5x 2019 EPS, but when normalized for

these factors, he finds 2019 price/earnings is closer to 16x-17x.

Mark Lipacis – Semiconductors

Franchise Pick – Texas Instruments (TXN, Buy, PT: $150) – Mark recently added

TXN to the Franchise Pick list as he believes the company is uniquely positioned to benefit

from several secular drivers as the industry shifts towards the next phase of growth--the

Internet of Things--and cyclical demand from industrial capex picks up. He notes that the

Auto and Industrial businesses grew by 18-21% in '17. Further, he expects the company

to expand GMs by 1,000bps as consolidation in semis drives further pricing power. His

new target assumes 23x our 2019 EPS of $6.51, a number that's well ahead of consensus,

though accounts for some tax reform benefits. His ’18 EPS estimate of $5.35 is 7% ahead

of consensus.

Materials

Laurence Alexander – Chemicals

Franchise Pick - Praxair (PX, Buy, PT: $186) – Stars finally appear be aligning given

a combination of favorable industrial production trends, evidence that merchant gas

pricing trends have turned the corner, a broader set of indicators and anecdotes

supporting the idea that the capex cycle has troughed and should become a tailwind to

industrial gas earnings later in the decade, progress on the merger with Linde and the

prospect of an extended cycle of portfolio optimization and capital returns that lift the EPS

CAGR into the low-to-mid teens.

Chris LaFemina – Metals & Mining

First Quantum (FM CN, Buy, PT: C$27) – 2018 marks a key inflection year for First

Quantum as Cobre Panama comes online in a phased commissioning starting in 2H18

(with commercial production starting in 2019). In addition, the company’s copper

hedges reset at higher levels, roll off completely, or are replaced by zero cost collars that

offer downside protection with upside leverage. Chris expects First Quantum’s free cash

flow to increase from negative $1.36/sh in 2017 to positive $3.56/sh (24.4% FCF yield) in

2020 as the company benefits from higher realized prices, higher volumes and lower

capex. The conversion of debt to equity with FCF starting in 2H18 should also be a

positive for FM shares.

Themes & Tactics

US Insights

January 31, 2018

page 16 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 17: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

Seth Rosenfeld – Steel

Steel Dynamics (STLD, Buy, PT: $54) – STLD remains one of Seth’s top picks in the

US steel sector as a high-quality play on the gradually tightening domestic steel market

and supported by bullish global trends led by Chinese supply-side reform. In the near-

term, STLD should benefit from greatly improving margins as steel prices continue to

move sharply higher following several rounds of price hikes launched in October. While

scrap input costs have also risen, flat steel margins have widened by 39%, driving bullish

expectations for STLD’s 1H18 earnings performance. Though US flat steel prices have

already rallied +$120/st since October, Seth believes prices may continue to increase

through 1H18 as the pre-existing inventory overhang is worked down, imports remain

uncompetitive and cede share to domestic steelmakers and demand seasonally improves

into spring. Imports may be structurally pushed out of the US through new trade

protections now under consideration through Section 232, which is expected to be

confirmed in the coming three months; however, Seth is hopeful that STLD’s long

products business should benefit from Section 232. Further, in the medium-term STLD is

leveraged to rising domestic demand across diversified end markets (infrastructure,

machinery, autos), which should allow STLD to better optimize its existing excess capacity

with notable fixed cost leverage as volumes rise. In addition, Seth views STLD as a key

winner from new US federal tax policy and management has noted they expect the

effective tax rate to fall to 24-25% from 36%. Although STLD trades at 7.7x CY18E

EV/EBITDA, a premium to its historical average of 5.7x and the US steel sector at 6.7x, Seth

believes a premium is merited.

Themes & Tactics

US Insights

January 31, 2018

page 17 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 18: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

Table 1: Stocks Selected by Jefferies Research

Ticker Name Analyst Rating

Price

Target

($)

Last

Price

($)

GICS Sector

Last FY

EPS

Growth

Est. '18

EPS

Growth

Est.

Rel. OM

Exp.

(bps)

Sector

OM Exp.

(bps)

Rel.

'17

Perf.

BIO BIO-RAD BRANDON COUILLARD BUY 300 263.41 Healthcare -34% 59% 260 89 10.9%

BLD TOPBUILD COR PHILIP NG BUY 89 76.36 Cons. Disc. 22% 38% 64 40 91.5%

CASY* CASEY'S GENER CHRISTOPHER MANDEVILLE BUY 143 124.25 Cons. Staples -21% -4% -110 57 -16.3%

CELG CELGENE CORP MICHAEL J YEE BUY 125 103.26 Healthcare 47% 45% 1963 89 -29.8%

CJ C&J ENERGY BRADLEY PHILIP HANDLER BUY 40 31.81 Energy - 6692% 479 423 -10.6%

CVX* CHEVRON JASON GAMMEL BUY 152 128.48 Energy -67% 47% -105 423 10.2%

ERI ELDORADO RES DAVID KATZ BUY 41 32.00 Cons. Disc. -66% 786% 440 40 74.3%

EXPE EXPEDIA INC BRENT THILL BUY 170 130.40 Cons. Disc. 30% 17% -155 40 -15.5%

FM CN FIRST QUANTU CHRISTOPHER LAFEMINA BUY 27 18.50 Materials 160% 1215% 1859 162 10.5%

GLNG GOLAR LNG RANDY GIVEANS BUY 40 28.27 Energy 34% 97% 10668 423 33.8%

GPS* GAP INC/THE RANDAL KONIK BUY 45 35.08 Cons. Disc. -17% 4% 83 40 30.6%

GT GOODYEAR ASHIK KURIAN BUY 42 35.66 Cons. Disc. 18% 30% 154 40 -16.6%

HAE HAEMONETICS ANTHONY PETRONE BUY 75 65.92 Healthcare -5% 25% 1417 89 24.5%

HOLX HOLOGIC INC RAJ DENHOY BUY 52 43.75 Healthcare 6% 77% -1482 89 -13.4%

KMT KENNAMETAL STEPHEN VOLKMANN BUY 60 49.57 Industrials 38% 69% 675 65 36.3%

KSS KOHLS CORP RANDAL KONIK BUY 100 67.95 Cons. Disc. -14% 17% 52 40 -11.4%

MCK MCKESSON BRIAN GIL TANQUILUT BUY 205 176.33 Healthcare 7% 13% -275 89 -9.0%

MLM MARTIN MAR PHILIP NG BUY 265 236.91 Materials 44% 30% 182 162 -21.6%

OMF ONEMAIN JOHN HECHT BUY 48 33.48 Financials 199% 34% 211 97 -2.6%

PAGP PLAINS GP CHRISTOPHER SIGHINOLFI BUY 26 22.23 Energy -35% 57% -298 423 -32.9%

PX* PRAXAIR INC LAURENCE ALEXANDER BUY 186 162.83 Materials 8% 13% -64 162 10.6%

SBGI SINCLAIR BROA JOHN JANEDIS BUY 48 38.85 Cons. Disc. 52% 72% 329 40 -7.7%

SBNY SIGNATURE BA CASEY HAIRE BUY 178 154.20 Financials 21% 25% 1411 97 -28.6%

SC* SANTANDER C JOHN HECHT BUY 23 18.62 Financials -8% 19% 219 97 17.9%

STLD STEEL DYNAMI SETH ROSENFELD BUY 54 47.32 Materials 37% 44% 1 162 -0.2%

SYNH SYNEOS HEALT DAVID WINDLEY BUY 55 40.75 Healthcare 33% 7% -517 89 -37.1%

TXN* TEXAS INSTRU MARK LIPACIS BUY 150 112.65 Technology 18% 20% -154 223 6.2%

TXT* TEXTRON INC SHEILA KAHYAOGLU BUY 68 61.22 Industrials 5% 30% 16 65 -2.0%

UAA* UNDER ARMOU RANDAL KONIK BUY 24 14.53 Cons. Disc. -9% 13% 18 40 -71.6%

ULTA ULTA BEAUTY STEPHANIE WISSINK BUY 300 229.15 Cons. Disc. 32% 26% -26 40 -33.5%

UTX UNITED TECH SHEILA KAHYAOGLU BUY 157 136.67 Industrials 1% 6% -136 65 -2.2%

WEX* WEX INC RAMSEY EL-ASSAL BUY 202 156.00 Technology -43% 27% 209 223 -10.4%

WMB WILLIAMS COS CHRISTOPHER SIGHINOLFI BUY 37 31.98 Energy -41% 65% 370 423 1.7%

Median: 8% 30% 82.5 Avg: -0.5%

Source: Bloomberg, Jefferies *Denotes Franchise Pick

Themes & Tactics

US Insights

January 31, 2018

page 18 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 19: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

Analyst Certification:I, Jefferies Equity Research, certify that all of the views expressed in this research report accurately reflect my personal views about the subjectsecurity(ies) and subject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specificrecommendations or views expressed in this research report.I, Laurence Alexander, CFA, certify that all of the views expressed in this research report accurately reflect my personal views about the subjectsecurity(ies) and subject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specificrecommendations or views expressed in this research report.I, Brandon Couillard, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.I, Raj Denhoy, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.I, Ramsey El-Assal, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.I, Jason Gammel, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.I, Randy Giveans, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.I, Casey Haire, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.I, Brad Handler, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.I, John Hecht, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.I, John Janedis, CFA, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.I, Sheila Kahyaoglu, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.I, David Katz, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.I, Randal J. Konik, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.I, Ashik Kurian, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.I, Christopher LaFemina, CFA, certify that all of the views expressed in this research report accurately reflect my personal views about the subjectsecurity(ies) and subject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specificrecommendations or views expressed in this research report.I, Mark Lipacis, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.I, Christopher Mandeville, CFA, certify that all of the views expressed in this research report accurately reflect my personal views about the subjectsecurity(ies) and subject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specificrecommendations or views expressed in this research report.I, Philip Ng, CFA, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.I, Anthony Petrone, CFA, certify that all of the views expressed in this research report accurately reflect my personal views about the subjectsecurity(ies) and subject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specificrecommendations or views expressed in this research report.I, Seth Rosenfeld, CFA, certify that all of the views expressed in this research report accurately reflect my personal views about the subjectsecurity(ies) and subject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specificrecommendations or views expressed in this research report.

Themes & Tactics

US Insights

January 31, 2018

page 19 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 20: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

I, Christopher Sighinolfi, CFA, certify that all of the views expressed in this research report accurately reflect my personal views about the subjectsecurity(ies) and subject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specificrecommendations or views expressed in this research report.I, Brian Tanquilut, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.I, Brent Thill, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.I, Stephen Volkmann, CFA, certify that all of the views expressed in this research report accurately reflect my personal views about the subjectsecurity(ies) and subject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specificrecommendations or views expressed in this research report.I, David Windley, CFA, CPA, certify that all of the views expressed in this research report accurately reflect my personal views about the subjectsecurity(ies) and subject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specificrecommendations or views expressed in this research report.I, Stephanie Wissink, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.I, Michael J. Yee, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) andsubject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendationsor views expressed in this research report.Registration of non-US analysts: Ashik Kurian is employed by Jefferies International Limited, a non-US affiliate of Jefferies LLC and is not registered/qualified as a research analyst with FINRA. This analyst(s) may not be an associated person of Jefferies LLC, a FINRA member firm, and therefore maynot be subject to the FINRA Rule 2241 and restrictions on communications with a subject company, public appearances and trading securities heldby a research analyst.As is the case with all Jefferies employees, the analyst(s) responsible for the coverage of the financial instruments discussed in this report receivescompensation based in part on the overall performance of the firm, including investment banking income. We seek to update our research asappropriate, but various regulations may prevent us from doing so. Aside from certain industry reports published on a periodic basis, the large majorityof reports are published at irregular intervals as appropriate in the analyst's judgement.

Company Specific DisclosuresFor Important Disclosure information on companies recommended in this report, please visit our website at https://javatar.bluematrix.com/sellside/Disclosures.action or call 212.284.2300.

Explanation of Jefferies RatingsBuy - Describes securities that we expect to provide a total return (price appreciation plus yield) of 15% or more within a 12-month period.Hold - Describes securities that we expect to provide a total return (price appreciation plus yield) of plus 15% or minus 10% within a 12-month period.Underperform - Describes securities that we expect to provide a total return (price appreciation plus yield) of minus 10% or less within a 12-monthperiod.The expected total return (price appreciation plus yield) for Buy rated securities with an average security price consistently below $10 is 20% or morewithin a 12-month period as these companies are typically more volatile than the overall stock market. For Hold rated securities with an averagesecurity price consistently below $10, the expected total return (price appreciation plus yield) is plus or minus 20% within a 12-month period. ForUnderperform rated securities with an average security price consistently below $10, the expected total return (price appreciation plus yield) is minus20% or less within a 12-month period.NR - The investment rating and price target have been temporarily suspended. Such suspensions are in compliance with applicable regulations and/or Jefferies policies.CS - Coverage Suspended. Jefferies has suspended coverage of this company.NC - Not covered. Jefferies does not cover this company.Restricted - Describes issuers where, in conjunction with Jefferies engagement in certain transactions, company policy or applicable securitiesregulations prohibit certain types of communications, including investment recommendations.Monitor - Describes securities whose company fundamentals and financials are being monitored, and for which no financial projections or opinionson the investment merits of the company are provided.

Valuation MethodologyJefferies' methodology for assigning ratings may include the following: market capitalization, maturity, growth/value, volatility and expected totalreturn over the next 12 months. The price targets are based on several methodologies, which may include, but are not restricted to, analyses of marketrisk, growth rate, revenue stream, discounted cash flow (DCF), EBITDA, EPS, cash flow (CF), free cash flow (FCF), EV/EBITDA, P/E, PE/growth, P/CF,P/FCF, premium (discount)/average group EV/EBITDA, premium (discount)/average group P/E, sum of the parts, net asset value, dividend returns,and return on equity (ROE) over the next 12 months.

Jefferies Franchise PicksJefferies Franchise Picks include stock selections from among the best stock ideas from our equity analysts over a 12 month period. Stock selectionis based on fundamental analysis and may take into account other factors such as analyst conviction, differentiated analysis, a favorable risk/reward

Themes & Tactics

US Insights

January 31, 2018

page 20 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 21: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

ratio and investment themes that Jefferies analysts are recommending. Jefferies Franchise Picks will include only Buy rated stocks and the numbercan vary depending on analyst recommendations for inclusion. Stocks will be added as new opportunities arise and removed when the reason forinclusion changes, the stock has met its desired return, if it is no longer rated Buy and/or if it triggers a stop loss. Stocks having 120 day volatility inthe bottom quartile of S&P stocks will continue to have a 15% stop loss, and the remainder will have a 20% stop. Franchise Picks are not intendedto represent a recommended portfolio of stocks and is not sector based, but we may note where we believe a Pick falls within an investment stylesuch as growth or value.

Risks which may impede the achievement of our Price TargetThis report was prepared for general circulation and does not provide investment recommendations specific to individual investors. As such, thefinancial instruments discussed in this report may not be suitable for all investors and investors must make their own investment decisions basedupon their specific investment objectives and financial situation utilizing their own financial advisors as they deem necessary. Past performance ofthe financial instruments recommended in this report should not be taken as an indication or guarantee of future results. The price, value of, andincome from, any of the financial instruments mentioned in this report can rise as well as fall and may be affected by changes in economic, financialand political factors. If a financial instrument is denominated in a currency other than the investor's home currency, a change in exchange rates mayadversely affect the price of, value of, or income derived from the financial instrument described in this report. In addition, investors in securities suchas ADRs, whose values are affected by the currency of the underlying security, effectively assume currency risk.

Other Companies Mentioned in This Report• Bio-Rad Laboratories (BIO: $263.41, BUY)• C&J Energy Services, Inc. (CJ: $31.81, BUY)• Casey’s General Stores, Inc. (CASY: $124.25, BUY)• Celgene Corporation (CELG: $103.26, BUY)• Chevron (CVX: $128.48, BUY)• Eldorado Resorts Inc (ERI: $32.00, BUY)• Expedia, Inc (EXPE: $130.40, BUY)• First Quantum (FM CN: C$18.50, BUY)• Golar LNG Limited (GLNG: $28.27, BUY)• Goodyear Tire & Rubber Co/The (GT: $35.66, BUY)• Haemonetics Corporation (HAE: $65.92, BUY)• Hologic, Inc. (HOLX: $43.75, BUY)• Kennametal Inc. (KMT: $49.57, BUY)• Kohl's Corporation (KSS: $67.95, BUY)• Martin Marietta Materials (MLM: $236.91, BUY)• McKesson Corporation (MCK: $176.33, BUY)• OneMain Holdings, Inc. (OMF: $33.48, BUY)• Plains GP Holdings, L.P. (PAGP: $22.23, BUY)• Praxair (PX: $162.83, BUY)• Santander Consumer USA Holdings (SC: $18.62, BUY)• Signature Bank (SBNY: $154.20, BUY)• Sinclair Broadcast Group (SBGI: $38.85, BUY)• Steel Dynamics, Inc. (STLD: $47.32, BUY)• Syneos Health (SYNH: $40.75, BUY)• Texas Instruments Incorporated (TXN: $112.65, BUY)• Textron Inc. (TXT: $61.22, BUY)• The Gap, Inc. (GPS: $35.08, BUY)• The Williams Companies, Inc. (WMB: $31.98, BUY)• TopBuild Corp. (BLD: $76.36, BUY)• Ulta Beauty (ULTA: $229.15, BUY)• Under Armour (UAA: $14.53, BUY)• United Technologies Corp. (UTX: $136.67, BUY)• WEX, Inc. (WEX: $156.00, BUY)

For Important Disclosure information on companies recommended in this report, please visit our website at https://javatar.bluematrix.com/sellside/Disclosures.action or call 212.284.2300.

Distribution of RatingsIB Serv./Past 12 Mos. JIL Mkt Serv./Past 12

Mos.Rating Count Percent Count Percent Count Percent

BUY 1103 53.31% 342 31.01% 66 5.98%HOLD 822 39.73% 161 19.59% 23 2.80%UNDERPERFORM 144 6.96% 20 13.89% 3 2.08%

Themes & Tactics

US Insights

January 31, 2018

page 21 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 22: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

Other Important DisclosuresJefferies does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that Jefferies may have aconflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investmentdecision.Jefferies Equity Research refers to research reports produced by analysts employed by one of the following Jefferies Group LLC (“Jefferies”) groupcompanies:United States: Jefferies LLC which is an SEC registered firm and a member of FINRA.United Kingdom: Jefferies International Limited, which is authorized and regulated by the Financial Conduct Authority; registered in England andWales No. 1978621; registered office: Vintners Place, 68 Upper Thames Street, London EC4V 3BJ; telephone +44 (0)20 7029 8000; facsimile +44 (0)207029 8010.Hong Kong: Jefferies Hong Kong Limited, which is licensed by the Securities and Futures Commission of Hong Kong with CE number ATS546; locatedat Suite 2201, 22nd Floor, Cheung Kong Center, 2 Queen’s Road Central, Hong Kong.Singapore: Jefferies Singapore Limited, which is licensed by the Monetary Authority of Singapore; located at 80 Raffles Place #15-20, UOB Plaza 2,Singapore 048624, telephone: +65 6551 3950.Japan: Jefferies (Japan) Limited, Tokyo Branch, which is a securities company registered by the Financial Services Agency of Japan and is a memberof the Japan Securities Dealers Association; located at Hibiya Marine Bldg, 3F, 1-5-1 Yuraku-cho, Chiyoda-ku, Tokyo 100-0006; telephone +813 52516100; facsimile +813 5251 6101.India: Jefferies India Private Limited (CIN - U74140MH2007PTC200509), which is licensed by the Securities and Exchange Board of India as a MerchantBanker (INM000011443), Research Analyst (INH000000701) and a Stock Broker with Bombay Stock Exchange Limited (INB011491033) and NationalStock Exchange of India Limited (INB231491037) in the Capital Market Segment; located at 42/43, 2 North Avenue, Maker Maxity, Bandra-KurlaComplex, Bandra (East) Mumbai 400 051, India; Tel +91 22 4356 6000.This material has been prepared by Jefferies employing appropriate expertise, and in the belief that it is fair and not misleading. The information setforth herein was obtained from sources believed to be reliable, but has not been independently verified by Jefferies. Therefore, except for any obligationunder applicable rules we do not guarantee its accuracy. Additional and supporting information is available upon request. Unless prohibited by theprovisions of Regulation S of the U.S. Securities Act of 1933, this material is distributed in the United States ("US"), by Jefferies LLC, a US-registeredbroker-dealer, which accepts responsibility for its contents in accordance with the provisions of Rule 15a-6, under the US Securities Exchange Act of1934. Transactions by or on behalf of any US person may only be effected through Jefferies LLC. In the United Kingdom and European EconomicArea this report is issued and/or approved for distribution by Jefferies International Limited and is intended for use only by persons who have, or havebeen assessed as having, suitable professional experience and expertise, or by persons to whom it can be otherwise lawfully distributed. JefferiesInternational Limited Equity Research personnel are separated from other business groups and are not under their supervision or control. JefferiesInternational Limited has implemented policies to (i) address conflicts of interest related to the preparation, content and distribution of research reports,public appearances, and interactions between research analysts and those outside of the research department; (ii) ensure that research analysts areinsulated from the review, pressure, or oversight by persons engaged in investment banking services activities or other persons who might be biased intheir judgment or supervision; and (iii) promote objective and reliable research that reflects the truly held opinions of research analysts and prevents theuse of research reports or research analysts to manipulate or condition the market or improperly favor the interests of the Jefferies International Limitedor a current or prospective customer or class of customers. Jefferies International Limited may allow its analysts to undertake private consultancywork. Jefferies International Limited’s conflicts management policy sets out the arrangements Jefferies International Limited employs to manage anypotential conflicts of interest that may arise as a result of such consultancy work. Jefferies International Ltd, its affiliates or subsidiaries, may make amarket or provide liquidity in the financial instruments referred to in this investment recommendation. For Canadian investors, this material is intendedfor use only by professional or institutional investors. None of the investments or investment services mentioned or described herein is available toother persons or to anyone in Canada who is not a "Designated Institution" as defined by the Securities Act (Ontario). In Singapore, Jefferies SingaporeLimited is regulated by the Monetary Authority of Singapore. For investors in the Republic of Singapore, this material is provided by Jefferies SingaporeLimited pursuant to Regulation 32C of the Financial Advisers Regulations. The material contained in this document is intended solely for accredited,expert or institutional investors, as defined under the Securities and Futures Act (Cap. 289 of Singapore). If there are any matters arising from, orin connection with this material, please contact Jefferies Singapore Limited, located at 80 Raffles Place #15-20, UOB Plaza 2, Singapore 048624,telephone: +65 6551 3950. In Japan this material is issued and distributed by Jefferies (Japan) Limited to institutional investors only. In Hong Kong,this report is issued and approved by Jefferies Hong Kong Limited and is intended for use only by professional investors as defined in the Hong KongSecurities and Futures Ordinance and its subsidiary legislation. In the Republic of China (Taiwan), this report should not be distributed. The researchin relation to this report is conducted outside the PRC. This report does not constitute an offer to sell or the solicitation of an offer to buy any securitiesin the PRC. PRC investors shall have the relevant qualifications to invest in such securities and shall be responsible for obtaining all relevant approvals,licenses, verifications and/or registrations from the relevant governmental authorities themselves. In India this report is made available by JefferiesIndia Private Limited. In Australia this information is issued solely by Jefferies International Limited and is directed solely at wholesale clients withinthe meaning of the Corporations Act 2001 of Australia (the "Act") in connection with their consideration of any investment or investment servicethat is the subject of this document. Any offer or issue that is the subject of this document does not require, and this document is not, a disclosuredocument or product disclosure statement within the meaning of the Act. Jefferies International Limited is authorised and regulated by the FinancialConduct Authority under the laws of the United Kingdom, which differ from Australian laws. Jefferies International Limited has obtained relief underAustralian Securities and Investments Commission Class Order 03/1099, which conditionally exempts it from holding an Australian financial serviceslicence under the Act in respect of the provision of certain financial services to wholesale clients. Recipients of this document in any other jurisdictionsshould inform themselves about and observe any applicable legal requirements in relation to the receipt of this document.

This report is not an offer or solicitation of an offer to buy or sell any security or derivative instrument, or to make any investment. Any opinion orestimate constitutes the preparer's best judgment as of the date of preparation, and is subject to change without notice. Jefferies assumes no obligationto maintain or update this report based on subsequent information and events. Jefferies, its associates or affiliates, and its respective officers, directors,and employees may have long or short positions in, or may buy or sell any of the securities, derivative instruments or other investments mentioned ordescribed herein, either as agent or as principal for their own account. Upon request Jefferies may provide specialized research products or servicesto certain customers focusing on the prospects for individual covered stocks as compared to other covered stocks over varying time horizons orunder differing market conditions. While the views expressed in these situations may not always be directionally consistent with the long-term views

Themes & Tactics

US Insights

January 31, 2018

page 22 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.

Page 23: US Insights 12th; Stocks That Can Still Work Finding Fresh ... · Ashik Kurian § Equity Analyst +44 (0)20 7029 8785 ashik.kurian@jefferies.com ... having the best EPS growth rate

expressed in the analyst's published research, the analyst has a reasonable basis and any inconsistencies can be reasonably explained. This materialdoes not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individualclients. Clients should consider whether any advice or recommendation in this report is suitable for their particular circumstances and, if appropriate,seek professional advice, including tax advice. The price and value of the investments referred to herein and the income from them may fluctuate. Pastperformance is not a guide to future performance, future returns are not guaranteed, and a loss of original capital may occur. Fluctuations in exchangerates could have adverse effects on the value or price of, or income derived from, certain investments. This report has been prepared independently ofany issuer of securities mentioned herein and not in connection with any proposed offering of securities or as agent of any issuer of securities. Noneof Jefferies, any of its affiliates or its research analysts has any authority whatsoever to make any representations or warranty on behalf of the issuer(s).Jefferies policy prohibits research personnel from disclosing a recommendation, investment rating, or investment thesis for review by an issuer priorto the publication of a research report containing such rating, recommendation or investment thesis. Any comments or statements made herein arethose of the author(s) and may differ from the views of Jefferies.

This report may contain information obtained from third parties, including ratings from credit ratings agencies such as Standard & Poor’s. Reproductionand distribution of third party content in any form is prohibited except with the prior written permission of the related third party. Third party contentproviders do not guarantee the accuracy, completeness, timeliness or availability of any information, including ratings, and are not responsible forany errors or omissions (negligent or otherwise), regardless of the cause, or for the results obtained from the use of such content. Third party contentproviders give no express or implied warranties, including, but not limited to, any warranties of merchantability or fitness for a particular purpose oruse. Third party content providers shall not be liable for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequentialdamages, costs, expenses, legal fees, or losses (including lost income or profits and opportunity costs) in connection with any use of their content,including ratings. Credit ratings are statements of opinions and are not statements of fact or recommendations to purchase, hold or sell securities. Theydo not address the suitability of securities or the suitability of securities for investment purposes, and should not be relied on as investment advice.

Jefferies research reports are disseminated and available primarily electronically, and, in some cases, in printed form. Electronic research issimultaneously available to all clients. Additional research products including models are available on Jefferies Global Markets Portal. This report orany portion hereof may not be reprinted, sold or redistributed without the written consent of Jefferies. Neither Jefferies nor any officer nor employee ofJefferies accepts any liability whatsoever for any direct, indirect or consequential damages or losses arising from any use of this report or its contents.

For Important Disclosure information, please visit our website at https://javatar.bluematrix.com/sellside/Disclosures.action or call 1.888.JEFFERIES

© 2018 Jefferies Group LLC

Themes & Tactics

US Insights

January 31, 2018

page 23 of 23 , Equity Analyst, (888) JEFFERIES, [email protected] Equity Research

Please see important disclosure information on pages 19 - 23 of this report.


Recommended